Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women
NCT01511835 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2012-01-19
Summary
The aim of this study is to evaluate the efficacy of myo-inositol in preventing gestational diabetes in high risk pregnant women.
Conditions
- Gestational Diabetes
Interventions
- DIETARY_SUPPLEMENT
-
inositol + folic acid
2000 mg of inositol+200mcg of folic acid; 2 per diem
- DIETARY_SUPPLEMENT
-
inositol + folic acid
600 mg of inositol + 200mcg of folic acid; 2 cp per diem
- DRUG
-
Folic Acid
Folic Acid 400mcg; 1 cp/die
Sponsors & Collaborators
-
AGUNCO Obstetrics and Gynecology Centre
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Italy
Study Locations
More Related Trials
-
Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women
NCT03951194 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)
NCT01266408 ·Status: COMPLETED
-
A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
NCT00796133 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
NCT00212342 ·Status: COMPLETED ·Phase: PHASE3
-
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01388491 ·Status: COMPLETED ·Phase: PHASE2
-
Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)
NCT00511433 ·Status: COMPLETED ·Phase: PHASE3
-
Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients
NCT05505435 ·Status: COMPLETED ·Phase: PHASE4
-
Cycle Control and Safety of E2-DRSP
NCT00653614 ·Status: COMPLETED ·Phase: PHASE2
-
EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT
NCT02293213 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121 ·Status: COMPLETED ·Phase: PHASE3
-
Does Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?
NCT05174195 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB
NCT02103764 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
NCT00461305 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Depot Medroxyprogesterone Acetate as Emergency Contraception
NCT03395756 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Structured Contraceptive Counseling During Pregnancy
NCT05550064 ·Status: RECRUITING ·Phase: NA
-
Pharmacodynamic Characterization of Dienogest
NCT00754871 ·Status: COMPLETED ·Phase: PHASE1
-
Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
NCT01482338 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause
NCT06513104 ·Status: COMPLETED ·Phase: PHASE1
-
The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth
NCT02571296 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant
NCT04047875 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility Study Into the Contraceptive Effect of Estetrol
NCT00563472 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
NCT03945513 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon
NCT01328184 ·Status: COMPLETED ·Phase: PHASE1
-
SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study
NCT00511797 ·Status: COMPLETED ·Phase: PHASE2/PHASE3